Genotype and Association of XRCC1 Gene With Liver Disease in Chronic Hcv Patients
- PMID: 40302092
- PMCID: PMC12227962
- DOI: 10.31557/APJCP.2025.26.4.1385
Genotype and Association of XRCC1 Gene With Liver Disease in Chronic Hcv Patients
Abstract
Chronic infections with hepatitis B virus (HBV) and hepatitis C virus (HCV) are well-established major risk factors for hepatocellular carcinoma (HCC). Nevertheless, only a minority of infected individuals progress to HCC in their lifetime, highlighting the potential influence of genetic factors in modulating susceptibility to this malignancy. The X-ray repair cross-complementing group (XRCC1) is involved in DNA repair pathways.
Aim: investigate the association between the c.24589 G>A single nucleotide polymorphism (SNP) of the XRCC1 gene and the risk of developing hepatocellular carcinoma (HCC) in patients with chronic hepatitis C virus (HCV) infection.
Methods: A case-control study was conducted in the oncology departments of Peshawar, Pakistan, involving 30 HCC patients and 30 cirrhotic HCV patients without HCC. After collecting relevant clinical data and basic laboratory tests,c.24589 G>A SNP of the XRCC1 gene was analyzed using the ARMS-PCR technique.
Results: A statistically significant higher frequency of XRCC1 (AA and GA) genotypes was observed in patients with hepatocellular carcinoma (HCC) compared to those with cirrhotic hepatitis C virus (HCV) (p = 0.0425). In addition, the A allele frequency was notably higher in the HCC group (54% compared to 23%, p = 0.0178). Moreover, multivariate analysis indicated that the c.24589 G>A SNP independently increased the risk of developing HCC by 4.58 times (95% CI: 1.7-11.88, p = 0.017). Furthermore, patients with the AA and GA genotypes displayed larger tumor sizes (p = 0.008), a greater number of tumor foci (p = 0.006), and higher Child-Pugh grades (p = 0.044).
Conclusion: XRCC1 gene polymorphism could be associated with increased risk of HCC development in chronic HCV patients.
Keywords: Chronic hepatitis C; DNA Repair; Genetic polymorphism; XRCC1 gene; liver disease.
Conflict of interest statement
I declare no conflict of interest in relation to this research. There are no financial, professional, or personal factors that could have influenced the study’s findings.
Figures
Similar articles
-
Association of XRCC1 Gene Polymorphism with an Increased Risk of Hepatocellular Carcinoma in the Peshawar Population.Asian Pac J Cancer Prev. 2025 Jun 1;26(6):2109-2115. doi: 10.31557/APJCP.2025.26.6.2109. Asian Pac J Cancer Prev. 2025. PMID: 40542773 Free PMC article.
-
Epidermal Growth Factor (EGF rs4444903) Gene Polymorphism and Risk of HCC in Egyptian HCV Cirrhotic Patients.Asian Pac J Cancer Prev. 2025 Jul 1;26(7):2577-2584. doi: 10.31557/APJCP.2025.26.7.2577. Asian Pac J Cancer Prev. 2025. PMID: 40729080
-
Interleukin-17A and Interleukin-17F Gene Polymorphisms in Egyptian Patients with Chronic Hepatitis C and Hepatocellular Carcinoma.Asian Pac J Cancer Prev. 2025 Jan 1;26(1):153-159. doi: 10.31557/APJCP.2025.26.1.153. Asian Pac J Cancer Prev. 2025. PMID: 39873997 Free PMC article.
-
NIH Consensus Statement on Management of Hepatitis C: 2002.NIH Consens State Sci Statements. 2002 Jun 10-12;19(3):1-46. NIH Consens State Sci Statements. 2002. PMID: 14768714
-
Association between XRCC1 Arg280His polymorphism and risk of hepatocellular carcinoma: a systematic review and meta-analysis.Genet Mol Res. 2015 Jun 29;14(2):7122-9. doi: 10.4238/2015.June.29.5. Genet Mol Res. 2015. PMID: 26125922
References
-
- Arghavanian Y, Adampour M, Pouladi N, Bagherlou N, Feizi HAM, Dastmalchi N, et al. The single nucleotide polymorphism arg399gln rs25487 in xrcc1 gene is a breast cancer risk factor, but is not related to tp53 mutation status. Genetika. 2020;52(3):867–79.
-
- Bhutta ZA, Hafeez A, Rizvi A, Ali N, Khan A, Ahmad F, et al. Reproductive, maternal, newborn, and child health in pakistan: Challenges and opportunities. Lancet. 2013;381(9884):2207–18. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical